NFL Biomarker May Be Unsuitable to Measure CMT1A Outcomes

NFL Biomarker May Be Unsuitable to Measure CMT1A Outcomes

315519

NFL Biomarker May Be Unsuitable to Measure CMT1A Outcomes

Blood levels of the protein neurofilament light chain (NFL), a biomarker of several neurological disorders, may not be suitable to measure outcomes in patients with Charcot-Marie-Tooth disease type 1A (CMT1A), a recent study suggests. The study, “A longitudinal and cross-sectional study of plasma neurofilament light chain concentration in Charcot-Marie-Tooth disease,” was published in the Journal of the Peripheral Nervous System. CMT disease is a genetic disorder characterized by damage to peripheral nerves that supply movement…

You must be logged in to read/download the full post.